Orange protection book?

What is an Orange Book classification?

The Orange Book, officially titled the Approved Drug Products with Therapeutic Equivalence Evaluations, is a database maintained by the United States Food and Drug Administration (FDA) that lists all approved brand-name and generic drugs in the country. A drug that has received an Orange Book classification is an approved drug product that has been listed in the Orange Book, meaning it has met certain criteria for safety, efficacy, and labeling.

How does a drug receive an Orange Book classification?

To receive an Orange Book classification, a drug must first be approved by the FDA through a new drug application (NDA) or abbreviated new drug application (ANDA). If the ANDA is for a drug that is already listed in the Orange Book, the generic version is considered a "therapeutically equivalent" version of the brand-name drug, but only if it has undergone clinical trials to demonstrate bioequivalence.

What are the benefits of being listed in the Orange Book?

Being listed in the Orange Book can provide several benefits to generic drug manufacturers. These include extended periods of market exclusivity, allowing them to recover costs and recoup their investments in developing the generic version of the drug. Additionally, approval in the Orange Book means that generic manufacturers will have a pathway to market, making it easier to gain regulatory approval for their product.

How does being listed affect the market exclusivity period?

In the United States, the Hatch-Waxman Act grants brand-name manufacturers exclusive rights to market a brand name prescription drug for a certain period, typically five to 11 years from the approval date of a generic version of the drug. During this exclusivity period, generic versions of the drug can be marketed, but the brand manufacturer may take action to enforce its patent rights and protect its market share.

Who maintains the Orange Book database?

The FDA is responsible for maintaining the Orange Book database. Drug manufacturers and sponsors may add their approved drug products for listing in the Orange Book after a new drug application is approved.

Where can you find the Orange Book database?

The Orange Book can be accessed through the official FDA website or through third-party databases that track pharmaceutical patents and trademarks, such as DrugPatentWatch.com [1].

References:

[1] DrugPatentWatch.com - Orange Book Listing